Evidence map›Paper›PMID 26136480›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature.

Khadija M Alawi, Aisah A Aubdool, Lihuan Liang, Elena Wilde, Abhinav Vepa, Maria-Paraskevi Psefteli, Susan D Brain, Julie E Keeble

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Synergistic combinations ofFrontiers in pharmacology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Khadija M Alawi*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom.
Aisah A Aubdool*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom.
Lihuan Liang*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom.
Elena Wilde*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom.
Abhinav Vepa*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom.
Maria-Paraskevi Psefteli*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom.
Susan D Brain*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom.
Julie E Keeble*Institute of Pharmaceutical Science and British Heart Foundation Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King's College London, London, United Kingdom julie.keeble@kcl.ac.uk.
King's College London · GBBritish Heart Foundation · GB

Funding

Arthritis Research UK 19296Biotechnology and Biological Sciences Research CouncilBritish Heart FoundationMedical Research CouncilNational Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K001531/1Versus Arthritis 20264
6 · The paper itself

Abstract

Transient receptor potential vanilloid 1 (TRPV1) is involved in sensory nerve nociceptive signaling. Recently, it has been discovered that TRPV1 receptors also regulate basal body temperature in multiple species from mice to humans. In the present study, we investigated whether TRPV1 modulates basal sympathetic nervous system (SNS) activity. C57BL6/J wild-type (WT) mice and TRPV1 knockout (KO) mice were implanted with radiotelemetry probes for measurement of core body temperature. AMG9810 (50 mg/kg) or vehicle (2% DMSO/5% Tween 80/10 ml/kg saline) was injected intraperitoneally. Adrenoceptor antagonists or vehicle (5 ml/kg saline) was injected subcutaneously. In WT mice, the TRPV1 antagonist, AMG9810, caused significant hyperthermia, associated with increased noradrenaline concentrations in brown adipose tissue. The hyperthermia was significantly attenuated by the β-adrenoceptor antagonist propranolol, the mixed α-/β-adrenoceptor antagonist labetalol, and the α1-adrenoceptor antagonist prazosin. TRPV1 KO mice have a normal basal body temperature, indicative of developmental compensation. d-Amphetamine (potent sympathomimetic) caused hyperthermia in WT mice, which was reduced in TRPV1 KO mice, suggesting a decreased sympathetic drive in KOs. This study provides new evidence that TRPV1 controls thermoregulation upstream of the SNS, providing a potential therapeutic target for sympathetic hyperactivity thermoregulatory disorders.

Indexed as

AcrylamidesAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-AntagonistsAnimalsBody TemperatureBody Temperature RegulationBridged Bicyclo Compounds, HeterocyclicFeverHumansInjections, IntraperitonealInjections, SubcutaneousLabetalolMaleMice, 129 StrainMice, Inbred C57BLMice, Knockout3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamideAcrylamidesAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-AntagonistsBridged Bicyclo Compounds, HeterocyclicLabetalolPrazosinPropranololReceptors, Adrenergic, alpha-1Receptors, Adrenergic, betaTRPV1 protein, mouseTRPV Cation Channelsbrown adipose tissuethermogenesisTRPV1

Identifiers

PMID26136480
PMCPMC4650996
OpenAlexW2118909983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.